- Home
- CLDT vs ADCT Comparison
CLDT vs ADCT Comparison
Compare CLDT & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDT
- ADCT
- Stock Information
- Founded
- CLDT 2009
- ADCT 2011
- Country
- CLDT United States
- ADCT Switzerland
- Employees
- CLDT N/A
- ADCT N/A
- Industry
- CLDT Real Estate Investment Trusts
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- CLDT Real Estate
- ADCT Health Care
- Exchange
- CLDT Nasdaq
- ADCT Nasdaq
- Market Cap
- CLDT 374.7M
- ADCT 380.2M
- IPO Year
- CLDT 2010
- ADCT 2020
- Fundamental
- Price
- CLDT $6.35
- ADCT $3.89
- Analyst Decision
- CLDT Strong Buy
- ADCT Strong Buy
- Analyst Count
- CLDT 2
- ADCT 6
- Target Price
- CLDT $10.75
- ADCT $7.60
- AVG Volume (30 Days)
- CLDT 293.6K
- ADCT 860.1K
- Earning Date
- CLDT 11-05-2025
- ADCT 11-10-2025
- Dividend Yield
- CLDT 5.62%
- ADCT N/A
- EPS Growth
- CLDT N/A
- ADCT N/A
- EPS
- CLDT 0.03
- ADCT N/A
- Revenue
- CLDT $310,140,000.00
- ADCT $77,246,000.00
- Revenue This Year
- CLDT N/A
- ADCT $11.78
- Revenue Next Year
- CLDT $0.52
- ADCT $4.83
- P/E Ratio
- CLDT $233.43
- ADCT N/A
- Revenue Growth
- CLDT N/A
- ADCT 15.73
- 52 Week Low
- CLDT $5.83
- ADCT $1.05
- 52 Week High
- CLDT $10.00
- ADCT $4.80
- Technical
- Relative Strength Index (RSI)
- CLDT 41.00
- ADCT 43.39
- Support Level
- CLDT $6.25
- ADCT $3.92
- Resistance Level
- CLDT $6.49
- ADCT $4.80
- Average True Range (ATR)
- CLDT 0.15
- ADCT 0.23
- MACD
- CLDT 0.02
- ADCT -0.07
- Stochastic Oscillator
- CLDT 46.15
- ADCT 0.54
About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).